News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quanterix Launches Multiplexed Single Molecule Immunoassay Technology to Improve Diagnosis and Potential Treatment of Complex Diseases


9/17/2013 9:53:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced its recently published Multiplexed Single Molecule Immunoassays study that successfully demonstrated the ability to measure multiple proteins simultaneously at the single molecule level using its Simoa technology. The study, published in May by the Royal Society of Chemistry, was funded in part by a grant from the National Cancer Institute.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Quanterix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES